慢加急性肝衰竭的预后评估模型及治疗研究现状
Current Status of Prognostic Evaluation Model and Treatment of Acute-on-Chronic Liver Failure
DOI: 10.12677/acm.2024.1441320, PDF,   
作者: 刘 念, 曾爱中*：重庆医科大学附属第一医院感染科，重庆
关键词: 慢加急性肝衰竭；预后评估模型；治疗；Acute-on-Chronic Liver Failure； Prognostic Evaluation Model； Treatment
摘要: 慢加急性肝衰竭(Acute-on-chronic liver failure, ACLF)是指在慢性肝病基础上，由于各种诱因引起的以急性肝功能损伤、凝血功能障碍为主要表现的一组临床症候群。该病起病急、进展快、预后差、短期病死率高，因此早期对ACLF患者进行准确的预后评估及治疗十分重要。本文主要就慢加急性肝衰竭的预后评估模型及治疗进展进行综述，旨在能为指导临床医疗、提高患者生存质量提供帮助。
Abstract: Acute-on-chronic liver failure (ACLF) refers to a group of clinical symptoms caused by acute liver function injury and coagulopathy on the basis of chronic liver disease. The disease has rapid onset, rapid progression, poor prognosis and high short-term mortality. Therefore, it is very important to carry out accurate prognosis assessment and treatment for ACLF patients in the early stage. This article mainly reviews the prognostic evaluation model and treatment progress of chronic acute liver failure, aiming to provide help for guiding clinical treatment, improving the quality of life of patients and rationally allocating medical resources.
文章引用：刘念, 曾爱中. 慢加急性肝衰竭的预后评估模型及治疗研究现状[J]. 临床医学进展, 2024, 14(4): 2500-2508. https://doi.org/10.12677/acm.2024.1441320

参考文献

[1] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学会分会重性肝病与人工肝学组. 肝衰竭诊治指南(2018年版) [J]. 临床肝胆病杂志, 2019, 35(1): 38-44.
[2] Bernal, W., Jalan, R., Quaglia, A., et al. (2015) Acute-on-Chronic Liver Failure. The Lancet, 386, 1576-1587. [Google Scholar] [CrossRef] 
[3] Arroyo, V., Moreau, R. and Jalan, R. (2020) Acute-on-Chronic Liver Failure. The New England Journal of Medicine, 382, 2137-2145. [Google Scholar] [CrossRef] 
[4] Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., et al. (1973) Transection of the Oesophagus for Bleeding Oesophageal Varices. British Journal of Surgery, 60, 646-649. [Google Scholar] [CrossRef] [PubMed]
[5] Yoo, J.J., Park, M.Y. and Kim, S.G. (2023) Acute Kidney Injury in Patients with Acute-on-Chronic Liver Failure: Clinical Significance and Management. Kidney Research and Clinical Practice, 42, 286-297. [Google Scholar] [CrossRef] [PubMed]
[6] Kamath, P.S., Wiesner, R.H., Malinchoc, M., et al. (2001) A Model to Predict Survival in Patients with End-Stage Liver Disease. Hepatology, 33, 464-470. [Google Scholar] [CrossRef] [PubMed]
[7] Yan, H., Wu, W., Yang, Y., et al. (2015) A Novel Integrated Model for End-Stage Liver Disease Model Predicts Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Patients. Hepatology Research, 45, 405-414. [Google Scholar] [CrossRef] [PubMed]
[8] Bai, C.Z., Ren, J., Zhang, X., et al. (2024) Global Acute-on-Chronic Liver Failure Trends during 2012-2022: A Bibliometric Study. Heliyon, 10, E25791. [Google Scholar] [CrossRef] [PubMed]
[9] Umemura, T., Shibata, S., Sekiguchi, T., et al. (2015) Serum Sodium Concentration Is Associated with Increased Risk of Mortality in Patients with Compensated Liver Cirrhosis. Hepatology Research, 45, 739-744. [Google Scholar] [CrossRef] [PubMed]
[10] Biggins, S.W., Kim, W.R., Terrault, N.A., et al. (2006) Evidence-Based Incorporation of Serum Sodium Concentration into MELD. Gastroenterology, 130, 1652-1660. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, W.R., Mannalithara, A., Heimbach, J.K., et al. (2021) MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology, 161, 1887-1895.E4. [Google Scholar] [CrossRef] [PubMed]
[12] Yi, N.J. (2024) See the Reality Again in the Field of Liver Transplantation. Nature Reviews Gastroenterology & Hepatology, 21, 74-75. [Google Scholar] [CrossRef] [PubMed]
[13] Vincent, J.L., Moreno, R., Takala, J., et al. (1996) The SOFA (Sepsis-Related Organ Failure Assessment) Score to Describe Organ Dysfunction/Failure. On Behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Medicine, 22, 707-710. [Google Scholar] [CrossRef] 
[14] Moreau, R., Jalan, R., Gines, P., et al. (2013) Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients with Acute Decompensation of Cirrhosis. Gastroenterology, 144, 1426-1437.E14379. [Google Scholar] [CrossRef] [PubMed]
[15] Dhiman, R.K., Agrawal, S., Gupta, T., et al. (2014) Chronic Liver Failure-Sequential Organ Failure Assessment Is Better than the Asia-Pacific Association for the Study of Liver Criteria for Defining Acute-on-Chronic Liver Failure and Predicting Outcome. World Journal of Gastroenterology, 20, 14934-14941. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, J.H., Jun, B.G., Lee, M., et al. (2022) Reappraisal of Sepsis-3 and CLIF-SOFA as Predictors of Mortality in Patients with Cirrhosis and Infection Presenting to the Emergency Department: A Multicenter Study. Clinical and Molecular Hepatology, 28, 540-552. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, Y., Nie, Y., Liu, L. and Zhu, X. (2020) Assessing the Prognostic Scores for the Prediction of the Mortality of Patients with Acute-on-Chronic Liver Failure: A Retrospective Study. PeerJ, 8, E9857. [Google Scholar] [CrossRef] [PubMed]
[18] Jalan, R., Saliba, F., Pavesi, M., et al. (2014) Development and Validation of a Prognostic Score to Predict Mortality in Patients with Acute-on-Chronic Liver Failure. Journal of Hepatology, 61, 1038-1047. [Google Scholar] [CrossRef] [PubMed]
[19] Hernaez, R., Solà, E., Moreau, R. and Ginès, P. (2017) Acute-on-Chronic Liver Failure: An Update. Gut, 66, 541-553. [Google Scholar] [CrossRef] [PubMed]
[20] Ramzan, M., Iqbal, A., Murtaza, H.G., et al. (2020) Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-on-Chronic Liver Failure. Cureus, 12, E7087. [Google Scholar] [CrossRef] [PubMed]
[21] Hareesh, G.J. and Ramadoss, R. (2024) Clinical Profile, Short-Term Prognostic Accuracies of CLIF-C ACLF Score and Serial CLIF-C of Scores in Acute-on-Chronic Liver Failure Patients: A Prospective Observational Study. Indian Journal of Critical Care Medicine, 28, 126-133. [Google Scholar] [CrossRef] [PubMed]
[22] Sarin, S.K., Choudhury, A., Sharma, M.K., et al. (2019) Acute-on-Chronic Liver Failure: Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL): An Update. Hepatology International, 13, 353-390. [Google Scholar] [CrossRef] [PubMed]
[23] Wu, T., Li, J., Shao, L., et al. (2018) Development of Diagnostic Criteria and a Prognostic Score for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Gut, 67, 2181-2191. [Google Scholar] [CrossRef] [PubMed]
[24] 马元吉, 杜凌遥, 白浪, 等. 六种预测模型对人工肝治疗的慢加急性肝衰竭患者短期预后的评估价值[J]. 四川大学学报(医学版), 2022, 53(5): 758-763.
[25] Li, J., Liang, X., You, S., et al. (2021) Development and Validation of a New Prognostic Score for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Journal of Hepatology, 75, 1104-1115. [Google Scholar] [CrossRef] [PubMed]
[26] Sun, L.J., Yu, J.W., Zhao, Y.H., et al. (2010) Influential Factors of Prognosis in Lamivudine Treatment for Patients with Acute-on-Chronic Hepatitis B Liver Failure. Journal of Gastroenterology and Hepatology, 25, 583-590. [Google Scholar] [CrossRef] [PubMed]
[27] Moreau, R. (2016) The Pathogenesis of ACLF: The Inflammatory Response and Immune Function. Seminars in Liver Disease, 36, 133-140. [Google Scholar] [CrossRef] [PubMed]
[28] Ferrigno, A., Gregotti, C., Richelmi, P., et al. (2010) Dexamethasone Protects Cultured Rat Hepatocytes against Cadmium Toxicity: Involvement of Cellular Thiols. In Vitro Cellular & Developmental Biology. Animal, 46, 445-449. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, P., Wang, Y.Y., Chen, C., et al. (2019) The Immunological Roles in Acute-on-Chronic Liver Failure: An Update. Hepatobiliary & Pancreatic Diseases International, 18, 403-411. [Google Scholar] [CrossRef] [PubMed]
[30] Dominari, A., Hathaway III, D., Pandav, K., et al. (2020) Thymosin Alpha 1: A Comprehensive Review of the Literature. World Journal of Virology, 9, 67-78. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, Y., Yang, F., Lu, H., et al. (2011) Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis. Hepatology, 54, 562-572. [Google Scholar] [CrossRef] [PubMed]
[32] Wan, Y.M., Li, Y.H., Xu, Z.Y., et al. (2017) Therapeutic Plasma Exchange versus Double Plasma Molecular Absorption System in Hepatitis B Virus-Infected Acute-on-Chronic Liver Failure Treated by Entercavir: A Prospective Study. Journal of Clinical Apheresis, 32, 453-461. [Google Scholar] [CrossRef] [PubMed]
[33] Yu, X., Liu, X., Tan, W., et al. (2024) The Clinical Courses of HBV-Related Acute-on-Chronic Liver Failure and a Multi-State Model to Predict Disease Evolution. Hepatology Communications, 8, E0354. [Google Scholar] [CrossRef] 

为你推荐